SHERRY BARRETT: Open Payments
NPI 1659532778 · ABINGDON, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$641 in 32 payments from 10 companies in 2025. Trend: 2023 $428 · 2024 $658 · 2025 $641
Food & beverage: $641
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 9 | $182 |
| Janssen Pharmaceuticals, Inc | 6 | $141 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $86 |
| Neurocrine BioSciences, Inc. | 4 | $81 |
| Vanda Pharmaceuticals Inc. | 3 | $53 |
| Teva Pharmaceuticals USA, Inc. | 2 | $32 |
| Lundbeck LLC | 1 | $17 |
| Otsuka America Pharmaceutical, Inc. | 1 | $17 |
| ABBVIE INC. | 1 | $16 |
| Alkermes, Inc. | 1 | $16 |
Products named: COBENFY, INVEGA SUSTENNA, CAPLYTA, INGREZZA, HETLIOZ, UZEDY, ABILIFY MAINTENA, REXULTI.
Industry payments across VA — which companies pay providers there.
